Cite
HARVARD Citation
Jin, J. et al. (2023). Complete response to tislelizumab in a metastatic urothelial carcinoma after surgery associated with high tumor mutational burden: a case report. Anti-cancer drugs. 34 (4), pp. 595-598. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jin, J. et al. (2023). Complete response to tislelizumab in a metastatic urothelial carcinoma after surgery associated with high tumor mutational burden: a case report. Anti-cancer drugs. 34 (4), pp. 595-598. [Online].